A global "health check" of the pharmaceutical industry by eyeforpharma surveyed 971 executives and found widespread optimism about the industry's prospects coupled with concern that its public reputation needs improvement. Almost everyone anticipated continued industry consolidation, and 59% foresaw the greatest competition coming from nontraditional players outside the field.

Full Story:
PharmaTimes (U.K.)

Related Summaries